Cambridge Crossing, a 45-acre development at the nexus of Cambridge, Boston, and Somerville, will provide another hub of tech and life sciences to the greater Boston area. The San Francisco-based developer, Divco West, has already begun construction on two structures within the complex as of this week, including a 430,000-square-foot office building intended to house science and tech groups. CBT Architects are the designers behind the master plan. Previously dubbed NorthPoint, the mega-development will include 4.5 million square feet of mixed-used space. Divco West has pitched the project as a more affordable alternative to Kendall Square, a neighborhood further south in Cambridge housing large tech companies like Amazon, Google, and Facebook, alongside pharmaceutical companies and start-ups. Cambridge Crossing will include five office buildings and nearly 2,400 condos or apartments. There will also be extensive ground-level retail space including restaurants and shops. Eleven acres have been set aside for a public park at the campus' center. "We've had some very good interest from prospective tenants already," Tom Sullivan, Divco West's president of development, told The Boston Globe. Office space within the development has been largely marketed toward tech, life science, and research groups, all thriving industries in Boston. The site could also potentially house part of Amazon's second headquarters, but not all of it–the tech giant's RFP requested up to eight million square feet of office space. In 2015, Divco West paid $291 million for the total acreage, which includes 17 individual parcels across what has been described as Cambridge's "last frontier"–the city's largest remaining infill development. The site will be even more accessible with the relocation of a Green Line light rail stop four minutes away. Plans for the development are moving through staggered permitting processes in each of the three cities involved. There is no set timeline for construction yet. Divco West expects the development to garner interest among organizations seeking cheaper spaces with more amenities in the increasingly expensive rental landscape of Boston.
Posts tagged with "biotech":
Boston is well known for both its thriving biotech industry and for its high concentration of universities, and now the city's two largest economic sectors are overlapping with several academic institutions shrewdly expanding their science departments. Northeastern University is one of several schools to hop on this bandwagon. The school just announced that it will build a 180,000-square-foot academic facility, called the Interdisciplinary Science and Engineering Building (ISEB). Boston-based firm Payette won the commission to design the six-story building along with adjoining green spaces after participating in a six week design competition. The site of the building sits on the opposite side of Northeastern's main campus, severed by several rail lines. Payette has proposed constructing what they've dubbed "The Arc," a curved pedestrian bridge, that provides access between the new building and Huntington Avenue, which will also serve as a direct connection between Fenway and Roxbury. A number of landscaped paths and open "tributaries" will link the two separate neighborhoods. The ISEB will house four academic research departments: engineering, health sciences, basic sciences, and computer sciences. According to the firm, the "building massing has been organized in two main volumes; an east facing laboratory bar and a west facing office form wrapped around a central open atrium." The facility will be divided into offices, staff workstations, conference rooms, cafes, and laboratories dedicated to each academic research study. The building features a glazed curtain wall that will "be wrapped with an outer skin of fixed solar shading responding to the building orientation." This $225 million project is the first component of Northeastern's larger plan to create 600,000 square feet of space for academic research and to accommodate the university's plan to add 300 faculty positions.
Agribusiness titan Monsanto has pledged hundreds of millions of dollars in upgrades to its research facility outside St. Louis, and design details are starting to pop up. Cannon Design will plan, design and engineer a new 400,000 square foot center for life sciences research. The expansion will bring 675 new employees to Chesterfield, on the western fringe of the St. Louis metropolitan area. Those jobs will be mainly high-paying research positions, encouraging for suburban Chesterfield after tax revenue sagged following 2009 layoffs at Pfizer, another major tenant of the business complex. But, as NextSTL points out, some urbanists would rather see such development closer to the urban core—namely in the CORTEX bioscience district in the city’s Central West End neighborhood. CORTEX would turn an old telephone factory and other industrial buildings into a biotech business district along Duncan Avenue.